101 related articles for article (PubMed ID: 2045937)
21. A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-L-tyrosine.
Kawai K; Fujibayashi Y; Saji H; Yonekura Y; Konishi J; Kubodera A; Yokoyama A
J Nucl Med; 1991 May; 32(5):819-24. PubMed ID: 2022989
[TBL] [Abstract][Full Text] [Related]
22. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas.
Weber WA; Dick S; Reidl G; Dzewas B; Busch R; Feldmann HJ; Molls M; Lumenta CB; Schwaiger M; Grosu AL
J Nucl Med; 2001 Aug; 42(8):1144-50. PubMed ID: 11483672
[TBL] [Abstract][Full Text] [Related]
23. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.
Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Samnick S; Maasjosthusmann U; Lerch H; Gildehaus FJ; Wassmann H; Schober O
Eur J Nucl Med; 1996 Oct; 23(10):1345-53. PubMed ID: 8781139
[TBL] [Abstract][Full Text] [Related]
24. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.
Grosu AL; Feldmann H; Dick S; Dzewas B; Nieder C; Gumprecht H; Frank A; Schwaiger M; Molls M; Weber WA
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):842-54. PubMed ID: 12377338
[TBL] [Abstract][Full Text] [Related]
25. Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.
Lahoutte T; Caveliers V; Franken PR; Bossuyt A; Mertens J; Everaert H
J Nucl Med; 2002 Sep; 43(9):1201-6. PubMed ID: 12215559
[TBL] [Abstract][Full Text] [Related]
26. 123I-IMT SPECT for evaluation of the response to radiation therapy in high grade gliomas: a feasibility study.
Kuczer D; Feussner A; Wurm R; Wust P; Michel R; Stockhammer F; Denecke T; Amthauer H; Felix R; Plotkin M
Br J Radiol; 2007 Apr; 80(952):274-8. PubMed ID: 17121760
[TBL] [Abstract][Full Text] [Related]
27. 3-[123I]iodo-alpha-methyl-L-tyrosine transport and 4F2 antigen expression in human glioma cells.
Langen KJ; Bonnie R; Mühlensiepen H; Jansen P; Bröer S; Holschbach M; Coenen HH
Nucl Med Biol; 2001 Jan; 28(1):5-11. PubMed ID: 11182559
[TBL] [Abstract][Full Text] [Related]
28. Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT.
Biersack HJ; Coenen HH; Stöcklin G; Reichmann K; Bockisch A; Oehr P; Kashab M; Rollmann O
J Nucl Med; 1989 Jan; 30(1):110-2. PubMed ID: 2783455
[TBL] [Abstract][Full Text] [Related]
29. Canine SPECT studies for cerebral amino acid transport by means of 123I-3-iodo-alpha-methyl-L-tyrosine and preliminary kinetic analysis.
Kawai K; Fujibayashi Y; Yonekura Y; Tanaka K; Saji H; Konishi J; Kubodera A; Yokoyama A
Ann Nucl Med; 1995 Feb; 9(1):47-50. PubMed ID: 7779531
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of 3-[(123)I]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells.
Riemann B; Stögbauer F; Kopka K; Halfter H; Lasic M; Schirmacher A; Kuwert T; Weckesser M; Ringelstein EB; Schober O
Eur J Nucl Med; 1999 Oct; 26(10):1274-8. PubMed ID: 10541825
[TBL] [Abstract][Full Text] [Related]
31. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
Lahoutte T; Mertens J; Caveliers V; Franken PR; Everaert H; Bossuyt A
J Nucl Med; 2003 Sep; 44(9):1489-94. PubMed ID: 12960197
[TBL] [Abstract][Full Text] [Related]
32. [The role of L-3-I-123-iodine-alpha-methyltyrosine SPECT in cerebral gliomas].
Weckesser M; Schmidt D; Matheja P; Coenen HH; Langen KJ
Nuklearmedizin; 2000 Dec; 39(8):233-40. PubMed ID: 11189900
[TBL] [Abstract][Full Text] [Related]
33. An artificial amino acid, 4-iodo-L-meta-tyrosine: biodistribution and excretion via kidney.
Shikano N; Kawai K; Flores LG; Nishii R; Kubota N; Ishikawa N; Kubodera A
J Nucl Med; 2003 Apr; 44(4):625-31. PubMed ID: 12679409
[TBL] [Abstract][Full Text] [Related]
34. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent.
Weckesser M; Griessmeier M; Schmidt D; Sonnenberg F; Ziemons K; Kemna L; Holschbach M; Langen K; Müller-Gärtner H
Eur J Nucl Med; 1998 Feb; 25(2):150-6. PubMed ID: 9473263
[TBL] [Abstract][Full Text] [Related]
35. Preparation and investigation of tumor affinity, uptake kinetic and transport mechanism of iodine-123-labelled amino acid derivatives in human pancreatic carcinoma and glioblastoma cells.
Samnick S; Schaefer A; Siebert S; Richter S; Vollmar B; Kirsch CM
Nucl Med Biol; 2001 Jan; 28(1):13-23. PubMed ID: 11182560
[TBL] [Abstract][Full Text] [Related]
36. Uptake mechanisms of L-3-[125I]iodo-alpha-methyl-tyrosine in a human small-cell lung cancer cell line: comparison with L-1.
Jager PL; de Vries EG; Piers DA; Timmer-Bosscha H
Nucl Med Commun; 2001 Jan; 22(1):87-96. PubMed ID: 11233558
[TBL] [Abstract][Full Text] [Related]
37. Relevance of image fusion with MRI for the interpretation of I-123 iodo-methyl-tyrosine scans in patients with suspected recurrent or residual brain tumor.
Amthauer H; Wurm R; Kuczer D; Ruf J; Michel R; Eisenacher J; Stockhammer F; Denecke T; Felix R; Plotkin M
Clin Nucl Med; 2006 Apr; 31(4):189-92. PubMed ID: 16550008
[TBL] [Abstract][Full Text] [Related]
38. In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport.
Lahoutte T; Caveliers V; Dierickx L; Vekeman M; Everaert H; Mertens J; Bossuyt A
Nucl Med Biol; 2001 Feb; 28(2):129-34. PubMed ID: 11295423
[TBL] [Abstract][Full Text] [Related]
39. Characterization of 3-[123I]iodo-L-alpha-methyl tyrosine ([123I]IMT) transport into human Ewing's sarcoma cells in vitro.
Franzius C; Kopka K; van Valen F; Eckervogt V; Riemann B; Sciuk J; Schober O
Nucl Med Biol; 2001 Feb; 28(2):123-8. PubMed ID: 11295422
[TBL] [Abstract][Full Text] [Related]
40. Brain tumor uptake of iodo-alpha-methyl-tyrosine.
Ell PJ
J Nucl Med; 1991 Nov; 32(11):2193-4. PubMed ID: 1941158
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
